老年肺癌治疗进展

被引：2

作者：

周彩存

陈晓霞

机构：

[1] 同济大学附属上海市肺科医院肿瘤研究所

来源：

老年医学与保健 | 2008年 / 04期

关键词：

老年肺癌; NSCLC; NVB; 最佳支持治疗; DDP; 中位生存期; MST; GEM; 单药治疗; 新辅助化疗;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

摘要：

<正>肺癌是世界上常见的恶性肿瘤,是癌症相关死亡的主要原因。肺癌又属于老年性疾病,50%以上晚期肺癌患者的发病年龄在≥65岁。最近流行病学调查及最终结果(surveillance epidemiology and end re- sults,SEER)资料显示,诊断时美国肺癌的中位发病年龄已达到71岁。

引用

页码：202 / 204+211 +211

页数：4

共 6 条

[1] A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older [J].

Chen, YM ;

Perng, RP ;

Chen, MC ;

Tsai, CM ;

Ming-Liu, J ;

Whang-Peng, J .

LUNG CANCER, 2003, 40 (02) :221-226

[2] Retrospective comparison of toxicity and efficacy in phase II trials of 3-h infusions of paclitaxel for patients 70 years of age or older and patients under 70 years of age [J].

Nakamura, Y ;

Sekine, I ;

Furuse, K ;

Saijo, N .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (02) :114-118

[3]

Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer[J] . S Ricci,A Antonuzzo,L Galli,C Tibaldi,M Bertuccelli,A Lopes Pegna,S Petruzzelli,R Algeri,V Bonifazi,M.L Fioretto,C Orlandini,P.F Conte.Lung Cancer . 2000 (2)

[4] Lung cancer in the elderly [J].

Gridelli, C ;

Perrone, F ;

Monfardini, S .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (14) :2313-2314

[5]

Lung cancer in the elderly .2 Gridelli C,Langer C,Maione P,et al. J Clin Oncol . 2007

[6]

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non- small-cell lung cancer .2 Frasci G,Lorusso V,Panxa N,et al. J Clin Oncol . 2000

← 1 →